Navigation Links
Next Breath Receives ISO/IEC 17025:2005 Accreditation from the American Association for Laboratory Accreditation
Date:2/19/2013

Baltimore, Maryland (PRWEB) February 19, 2013

Next Breath, LLC, a Specialty Contract Research Organization (CRO) with expertise in analytical testing of pulmonary, nasal drug, and ophthalmic delivery systems, announced today that the company received its ISO (the International Organization for Standardization) and IEC (the International Electrotechnical Commission) 17025:2005 accreditation from the American Association for Laboratory Accreditation (A2LA). Compliance with this standard provides a globally accepted basis for laboratory accreditation. The standard specifies the management and technical requirements to be met by testing and calibration laboratories in both the organization and management of quality.

The ISO/IEC 17025:2005 also covers testing and calibration performed using standard methods, non-standard methods, and laboratory-developed methods. This accreditation is another illustration of Next Breath’s commitment to quality and technical expertise, and adherence to the highest standards in quality management systems.

Julie Suman, President, says, “We are very pleased with this accreditation, which confirms Next Breath’s commitment to meeting and exceeding the highest quality standards. We work diligently to maintain regulatory standards and we have once again demonstrated our ability to sustain and continuously improve quality systems within our organization.”

About A2LA

A2LA is non-profit, non-governmental, public service, membership society. A2LA also offers programs for the accreditation of testing laboratories, calibration laboratories, inspection bodies, proficiency testing providers, medical testing laboratories, reference material producers and product certification bodies.

About Next Breath

Next Breath, a member of the AptarGroup, is a cGMP contract services organization for pharmaceutical, biotech and medical device companies that bring pulmonary, nasal, and ophthalmic drug products to market. Next Breath provides comprehensive solutions to the development processes from proof of concept to commercialization. Next Breath has led successful submissions for pulmonary and nasal drug products and devices in the US and international markets.

For more information please visit http://www.nextbreath.net or http://www.aptar.com

Contact Next Breath
Badre Hammond, MBA
+(1)352-642-2141 / badre(dot)hammond(at)nextbreath(dot)net

Read the full story at http://www.prweb.com/releases/2013/2/prweb10435177.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Breathe Better With Clarity Allergy Center
2. Medzilla.com Special Report: Unemployed Can Breathe a Little Freer After Supreme Court's Affordable Care Act Ruling
3. OsteoFab™ Patient Specific Cranial Device Receives 510(k) Approval
4. Discovery Labs Receives $30 Million Funding Commitment from Deerfield Management
5. Venaxis Executes First Commercial Development Agreement and Receives Purchase Order from EMELCA Bioscience for Initial EU Launch
6. OsteoVantage™ Receives Grant from the National Science Foundation
7. Avillion LLP Receives Initial Funding From Abingworth and Clarus
8. St. Mark’s School Receives $4.8 Million Gift from Tech Pioneer Graduate
9. RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
10. RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
11. BioNeutral Group Receives Positive Testing Results From A Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... ... January 13, 2017 , ... Two Kalamazoo ... compound called fulvic acid that farms, greenhouses and hydroponics operations use to increase ... among the fastest growing segments of customers using this high grade fulvic acid ...
(Date:1/12/2017)... ... 2017 , ... Each year, Crain’s Detroit Business News ranks the most innovative ... patent estate of a company, its impact and significance, and the likelihood of bringing ... in technologies that transform energy sources such as low dose X-ray and convert them ...
(Date:1/12/2017)... DC , January 12, 2017 ... up the world,s biggest facility for producing mycorrhizae. The ... the nutrient tapping potential of mycorrhizae and developed a ... ... (Logo: http://mma.prnewswire.com/media/456932/PRNE_TERI_Logo.jpg) The TERI facility ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... of Limfinity® Cloud, RURO has enhanced the platform to accommodate increasingly complex ... login, rapid data searching, and more. In addition to these improvements, the ...
Breaking Biology Technology:
(Date:12/15/2016)... --  WaferGen Bio-systems, Inc. (NASDAQ: WGBS ... that on December 13, 2016, it received a letter ... Market LLC which acknowledged that, as of December 12, ... had been at $1.00 or greater for ten consecutive ... Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... LONDON , Dec. 14, 2016 "Increase ... mobile biometrics market" The mobile biometrics market is expected ... USD 49.33 billion by 2022, at a CAGR of ... by factors such as the growing demand for smart ... mobile transactions. "Software component is expected to ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):